Gene Query: PHF20

Dataset Description Geneva Score
PHF20 readers link methylation of histone H3K4 and p53 with H4K16 acetylation 46.05
Global gene expression profiling from LeuCAG3'tsRNA depleted- HeLa and HCT-116 cell lines through 50 base pair paired-end RNA-seq 25.64
Cellular acidosis triggers MondoA transcriptional activity by driving mitochondrial ATP production 21.98
Effects of Cardiac Glycosides on RNA Expression in Prostate Cancer LNCaP-abl Cells 21.43
Transcriptome profiling in primary human skeletal myotubes with MondoA knockdown 18.75
MondoA Links Muscle Lipid Accumulation and Insulin Resistance Driven by Nutrient Overload 18.75
Targeting EZH2 in MYCN-amplified Neuroblastoma [RNA-seq] 18.57
Targeting EZH2 in MYCN-amplified Neuroblastoma 18.57
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 16.87
Effect of OVO-like 1 knockdown on global transcript expression in differentiated BeWo trophoblast cells 16.67
Peroxisome Proliferator-activated Receptor gamma- Deficiency in Endothelial Cells Impairs Angiogenic Capacity by Loss-of E2F1 Mediated Wnt Effector Genes 16.63
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 16.5
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HET] 16.29
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator 16.02
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] 16.02
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (3' RNA) 15.57
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma 15.47
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 15.08
RNA-Seq comparisons of gene expression profiles of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 14.74
ChIP-seq and RNA-Seq analyses of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 14.74
RNA-seq analysis of SKMEL28 melanoma cells following DIRC3 and IGFBP5 ASO knockdown 14.11
Unique features and clinical importance of acute alloreactive immune responses 13.91
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of binding sites in a cell type-specific manner 13.67
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 13.36
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 12.68
ETV7 and interferon response 12.68
The effect of doxycycline-induced expression of host-cell-factor 2 (HCF-2) proteins on the global gene expression in HEK-293 cells 12.6
KMT2C medaites the estrogen dependence of breast cancer through regulation of ERα enhancer function 12.45
Identifying the molecular mode of action of itraconazole in colorectal cancer 12.34
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 11.27
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 11.19
Heterogeneous nuclear ribonucleoprotein C1/C2 links transcriptional and splicing actions of 1,25-dihydroxyvitamin D 10.72
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia 10.53
Integrated multi-omics approach reveals a role of ALDH1A1 in lipid metabolism in human colon cancer cells 10.42
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis 10.16
Next Generation Sequencing upon siRNA-mediated knockdown of DRAIC in MCF-7 cells. 10.15
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 10.14
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 10.14
Genes significantly down or Up-regulated upon RNF219 knockdown 10.14
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 10.11
Neutrophils in systemic onset Juvenile Idiopathic Arthritis display sepsis-like features which can be reverted by IL-1 blockade 10.05
RNA sequencing of ESC/iPSC-derived purified PAX6-GFP neural progenitors form control and Phelan-Mcdermid patients 10.01
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 10.01
Nuclear import of the DSCAM-cytoplasmic domain drives signaling capable of inhibiting synapse formation 9.99
Expression profile of Lo19S state cells in the presence and absence of bortezomib treatment 9.94
Estrogen receptor and mTOR signaling rewires cancer metabolism in obesity-associated breast cancer 9.88
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 9.74
Integrating single-cell transcriptomic data across different conditions, technologies, and species 9.71
Activation of a SOX2-dependent transcriptional regulatory circuit drives glioblastoma. 9.69
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 9.61
STVI-120 Induction of differentiation in human epidermal stem cells followed by differential splicing analysis 9.52
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 9.48
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 9.48
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 9.46
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines HSB2 and RPMI8402 9.34
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 9.34
Expression by CD133+ cells isolated from the adult human exocrine pancreas 9.2
RNA-seq in untreated and flagellin-treated Human Intestinal Myofibroblast cells (HIMF) 9.17
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 9.1
Transcript abundance in A-T-derived iPSC: Comparing isogenic cells to unrelated individual 9.03
Transcriptomes change differerntly in differernt cancer cells upon EPZ-6438 treatment 8.91
Proteotranscriptomic profiling of potential E6AP targets in prostate cancer cells 8.88
Codon usage optimization in pluripotent embryonic stem cells [RNA-seq] 8.88
Transcriptional landscape changes during human embryonic stem cell derivation 8.85
GIST cell cycle dysregulation is required for progression to high-risk disease but not for resistance to kinase inhibitors 8.76
The evolution of N6-methyladenosine in primates 8.68
Sequencing-based analyses characterize a tumor suppressive role of mir-1271 repressed by DNA hypermethylation in gastric cancer 8.67
A prostate cancer chromatin interaction map 8.62
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis [MultiDisease] 8.57
Function of HNRNPC in breast cancer cells by controlling the dsRNA-induced interferon response 8.55
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 8.52
Genome wide miR-191 target profile determined by RIP and gene expression profiling 8.52
Mitotically associated long non-coding RNA, MANCR regulates cell cycle in triple negative breast cancer cells  8.5
Profiling of circular RNAs in gastric cancer tissues and adjacent normal tissues 8.46
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 8.33
AR-independent prostate cancer is sustained through FGF signaling 8.32
Inhibition of SF3B1 by molecules targeting the spliceosome in Rh18 cells 8.29
G9a-Mediated Methylation of ERα Links the PHF20/MOF Histone Acetyltransferase Complex to Hormonal Gene Expression 8.26
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 8.25
Neurofibroma 8.21
Differential expression in wild-type and mutant neurofibroma and MPNST cell lines 8.21
Epigenome-wide Effects of Vitamin-D on Bronchial Epithelial Cells using ATAC-Seq and RNA-seq 8.2
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 8.2
CD95L derived si- and shRNAs kill cancer cells through an RNAi mechanism by targeting survival genes [shL3.shR6.RNAseq.lg] 8.16
U1 snRNP telescripting regulates size-function stratified human genome 8.08
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells [RNA-seq] 8.02
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells 8.02
Gene expression analysis of ER+ and ER- breast cancer cell lines with acquired resistance to palbociclib 8.02
Effect of drugs on transcriptomic profiles 8.0
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 7.99
XBP1s Activation Globally Remodels N-Glycan Structure Distribution Patterns 7.92
Novel Targeting of Transcription and Metabolism in Glioblastoma 7.91
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 7.78
RNA-Seq analysis of primary human keratinocytes exposed to Cannabidiol 7.58
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 7.52
Nm-seq finds thousands of modified 2’-O-methylation sites in mRNA with base precision 7.5
Comparison of the transcriptome and chromatin state between human cord blood HSC and human iPSC derived hematopoietic progenitor using next-generation sequencing 7.44
The effect of spontaneous acquisition of an extra chromosome 7 for engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 7.43
Differential responses by human respiratory epithelial cell lines to respiratory syncytial virus reflect distinct patterns of infection control 7.43
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia [RNA-seq] 7.4
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia 7.4
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 7.4
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 7.35
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 7.3
Alu RNA modulates the expression of cell cycle genes in human fibroblasts 7.3
The cohesin release factor WAPL restricts chromatin loop extension. 7.3
The cohesin release factor WAPL restricts chromatin loop extension. [RNA-Seq] 7.3
Identification of renal resident macrophages across species 7.27
RNA-seq analysis of AML cells in response to ASLAN003 7.26
A novel CD4+ T cell population expanded in SLE blood provides B cell help through IL10 and succinate 7.22
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 7.19
Widespread intronic polyadenylation diversifies immune cell transcriptomes 7.17
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 7.16
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 7.14
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 7.13
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines 7.12
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 7.02
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 7.01
Whole-Transcriptome Profiling of Canine and Human in Vitro Models Exposed to a G-Quadruplex Binding Small Molecule 6.98
Survival of pancreatic cancer cells lacking KRAS function 6.98
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 6.9
Downregulation of DDX5/DDX17 and REST 6.9
Effect of CHKA knockdown on C4-2 cell transcriptome 6.85
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 6.84
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 6.83
ETS family proteins bind glucocorticoid receptor: relevance for treatment of Ewing sarcoma 6.83
Comparative whole-transcriptomic analysis between normal and AKAP-Lbc-depleted human embryonic stem cells 6.75
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells [RNA-seq] 6.74
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells 6.74
Cerebellar differentiation in Ataxia-Telangiectasia 6.73
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 6.7
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 6.7
CROP-Seq in Primary Human T Cells 6.68
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability [ RNA-seq] 6.68
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability 6.68
Next generation sequencing of small RNAs isolated from exosomes in human semen 6.68
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 6.67
Ribosomal footprinting of CN34-Parental and CN34-LM1a 6.64
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 6.64
Single-nucleotide-resolution mapping of HBV promoters using CAGE 6.62
Ribosomal footprinting of MDA-Parental and MDA-LM2 6.6
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 6.56
Preliminary Report of Transplantation of Human Fetal Retinal Pigment Epithelial Cells on Age-related Macular Degeneration Patients 6.54
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition 6.48
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition [RNA-Seq] 6.48
Single-cell transcriptome of human epithelial cells reveals novel insights into early innate immune responses to influenza virus and viral antagonism 6.46
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination 6.45
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 6.43
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 6.43
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 6.4
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 6.4
Expression analysis of Mebendazole treated THP-1 cells in three paired samples 6.4
Analysis of regulatory element evolution between human and mouse reveals a lack of cis-trans compensation 6.36
miRNA-1343 attenuates pathways of fibrosis by targeting the TGF-beta receptors [RNA-seq] 6.34
FMRP facilitates the nuclear export of N6-methyladenosine-containing mRNAs 6.31
Single-cell ID-seq identifies BMP signaling as a driver of a late stage epidermal differentiation program. 6.27
Effect of BMP inhibition or stimulation of primary human keratinocytes 6.27
Biological effect of chronic mistranslation in mammalian cells 6.26
ChIP-seq of ER and RUNX2 in MCF7 breast cancer cell lines 6.22
MOF acetyl transferase regulates transcription and respiration in mitochondria 6.21
PR isoform-specific ER and PR chromatin binding and gene expression observed in-vitro in breast cancer cells. 6.19
mRNA expression levels in splenic human mononuclear cells of mock- and HIV-1-infected humanized mice 6.17
Expression profiling of etoposide-induced senescent cells 6.17
RNAseq of Extracellular vesicle RNAs and cellular RNAs from HPASMCs with or without TGF-b1 or BMP4 treatment 6.16
mRNA expression profile of Lymphocytes 6.16
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 6.15
Human lymph nodes maintain a unique subset of resident memory T cells with high functional potential important for protective immunity and immunotherapies 6.15
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. 6.09
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 6.07
Global analysis of enhancer targets: Mosaic-seq 6.04
Transcriptome of human keratinocytes with or without HPV16 oncogene expression 6.03
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation II 6.03
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 6.02
Induction of extracellular adenosine salvage and metabolic quiescence regulate the transitional to follicular B cell checkpoint in humans. 6.02
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 6.0
Gene expression in skeletal muscle in older individuals subject to ten days of complete bed rest. 5.99
RNA-seq profiling of the human neutrophil genome during PMA- and E. coli encounter-induced activation 5.97
Human neutrophil genome during PMA- and E. coli encounter-induced activation 5.97
Gene expression in GBM with Cav3.2 inhibition 5.93
Androgen Receptor-regulated genes in prostate cancer cells 5.91
RNA-seq profiling identifies Androgen Receptor-regulated genes in prostate cancer cells 5.91
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma [RNA-Seq] 5.9
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma 5.9
RNA-seq Profiles in RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 5.89
RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 5.89
Transcriptional Signatures of Hypoxic and Inflammatory Renal Epithelial Injury 5.87
Treatment of multiple myeloma cells with EZH2 small molecule inhibitor 5.87
Differentially expressed vascular development genes for iPSC-ECs from CDI 5.86
Parvovirus B19 NS1 protein induces cell cycle arrest at G2 phase 5.85
Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs 5.79
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 5.79
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming 5.79
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq Human] 5.78
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 5.76
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [RNA-seq] 5.76
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies 5.76
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 5.74
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 5.73
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] 5.73
Epigenome regulation during epidermal lineage commitment [RNA-seq] 5.72
Effect of from Human Umbilical Vein Endothelial Cells 5.71
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis 5.68
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis [RNA-seq] 5.68
Effect of PBK knockdown on C4-2 cell transcriptome 5.66
IMP3 regulated gene expression in breast cancer cells 5.64
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins 5.63
Patient-derived luminal breast cancer xenografts with progestins 5.63
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq2] 5.63
scRNASeq analysis of cycling cardiomyocytes 5.59
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 5.53
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 5.53
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 [RNA-seq] 5.52
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 5.52
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 5.52
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 5.51
Transcriptomic analysis of the HOTAIR-regulated genes 5.51
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 5.5
Molecular Criteria for Defining the Naive Human Pluripotent State 5.49
RNA-seq of naive and primed ES cells 5.46
Direct Isolation and Characterization of Human Nephron Progenitors. 5.45
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors 5.42
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 5.41
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 5.4
Characterization of sperm lncRNA and its differently expression in the sperm of asthenozoospermic patients 5.39
RNA-Sequencing experiment for effects of PKF115-584 treatment on four T-ALL cell lines (RPMI8402, HPB-ALL, Jurkat, CCRF-CEM). 5.29
Gene expression changes upon drug withdrawal (A375/451Lu cell lines) 5.29
Effect of CRISPR-Cas9 mediated knock-out of integrin alpha2 on the transcriptome of DU145 prostate cancer cell grown as a spheroid culture 5.26
Transcriptome Analysis of CircMRPS35 mediated mRNA expression profiles 5.26
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 5.24
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 5.24
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 5.23
Network-based, cross-cohort discovery of transcriptional mechanisms presiding over maintenance of high-risk neuroblastoma subtype state 5.2
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming 5.18
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming (RNA-seq fibroblasts) 5.18
Transcriptional profile of CAOV2 primary and CAOV2 recurrent cells 5.16
Transcriptome profile of HepG2-expressing ATP7B-H1069Q (liver hepatocellular cells) exposed to JNK or p38 Inhibitor 5.16
Transcriptome of activated human and mouse MAIT cells 5.16
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors [RNA-seq] 5.15
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors 5.15
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 5.15
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 5.06
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 5.03
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 4.98
MeRIP-seq for heat shock in B-cell lymphoma cells 4.97
Identification of renal resident macrophages across species [C1] 4.96
MYCL and EP400 are required for Max and MCPyV mediated gene activation 4.94
ROR-γ drives androgen-receptor expression and represents a therapeutic target in castration-resistant prostate cancer 4.93
Transcriptome analysis in Neobractatin treated cells 4.91
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 4.88
Genomic and proteomic resolution of heterochromatin and its restriction of alternate fate genes (RNA-seq) 4.86
Genomic and proteomic resolution of heterochromatin and its restriction of alternate fate genes 4.86
Epigenetic siRNA and chemical screens identify SETD8 inhibition as a new therapeutic strategy of p53 reactivation in high-risk Neuroblastoma. 4.81
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells 4.81
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 4.76
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 4.74
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma 4.74
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] 4.74
STX4 Over-Expression in Human islets 4.73
The effect of Abl kinases on non-small cell carcinoma global transcriptome 4.72
NOTCH1 activation in breast cancer confers sensitivity to inhibition of SUMOylation 4.7
MRTF activates TEAD-YAP target gene expression 4.69
Genes regulated by soluble guanylyl cyclase in VCaP prostate cancer cells 4.66
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 4.62
ATF7IP-mediated stabilization of the histone methyltransferase SETDB1 is essential for heterochromatin formation by the HUSH complex 4.56
Assessing the impact of loss of ATF7IP and SETDB1 on the transcriptome 4.56
The bromodomain protein BRD4 regulates splicing during heat shock 4.54
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 4.53
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 4.53
Comparing effects of perfusion and hydrostatic pressure on human chondrocytes using gene profiles 4.51
Global transcriptome analysis of HAP1 cells 4.48
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 4.42
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 4.39
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 4.39
Identification of elevated A-to-I editing sites due to expression of an active ADAR3 mutant in human glioblastoma cells 4.38
Next Generation Sequencing upon siRNA-mediated knockdown of EIF5A in MCF-7 cells. 4.38
Mapping interactions for the TNIP2 hub protein 4.35
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 4.34
Group A Streptococcus M1T1 Intracellular Infection of Primary Tonsil Epithelial Cells Dampens Levels of Secreted IL-8 Through the Action of SpyCEP 4.33
Differentially Expressed Genes upon Knockdown of ZRANB1 or EZH2 in LM2 Cells 4.32
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) 4.26
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process 4.26
Integration of genome-wide DNA methylome and transcriptome of human intestinal fibroblasts reveals novel candidate gene signatures in Crohn’s disease-associated fibrosis 4.25
PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer 4.18
Zika virus antagonizes interferon response in patients and disrupts RIG-I-MAVS interaction through its CARD-TM domains 4.15
Contribution of SRF and Nkx2-5 to androgen-dependent gene expression in prostate cancer 4.14
Meta-organization of Translation Centers Revealed by Proximity Mapping of Endoplasmic Reticulum Ribosome Interactors 4.12
Differential YAP expression in glioma cells induces cell competition and promotes tumorigenesis 4.02
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 3.99
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 3.98
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with ENST00000431060 shRNA or control shRNA 3.97
Epidermal growth factor activates β-catenin via integrin-linked kinase to control proliferation of mesenchymal stromal cells. 3.94
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 3.94
Generation and persistence of human tissue-resident memory T cells in lung transplantation 3.94
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 3.92
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 3.92
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (LNCaP RNA-seq) 3.88
Exploring transcriptomic landscapes in red cell populations, in their extracellular vesicles and on single cell level 3.83
Oncogenic changes and EMT in normal human bile duct epithelial cells are caused by parasite-derived materials and N-nitrosodimethylamine 3.8
Landscape of human mast cell chromatin: a rich resource for identification of novel mediators and genetic drivers of allergic and inflammatory diseases 3.75
Transcriptomic profiling of human CD34+ derived mast cells [RNA-Seq] 3.75
Capturing the Interactome of Newly Transcribed RNA (RICK) 3.72
Capturing the Interactome of Newly Transcribed RNA 3.72
POLR3G Dependent PolyA+ and smallRNA Transcriptomes in Human Pluripotent Stem Cells 3.72
RNA-seq analysis of SLIRP knockdown with 1nM DHT in LNCaP cells 3.71
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors 3.71
Characterization of EZH2-deficient human embryonic stem cells [ChIP-seq and bulk RNA-seq] 3.64
Identification of epigenetic interactions between miRNA and DNA methylation associated with polycystic ovarian syndrome 3.64
Transcriptome Profiling Reveals the key genes and pathways involved in polycystic ovary syndrome [RNA-seq] 3.64
Expression analysis of primary human monocytes stimulated with an anti-TLR10 mAb (5C2C5) 3.6
Antiviral innate immunity of hepatitis C virus-infected stem cell-derived hepatocytes 3.57
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency 3.53
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency (RNA-Seq) 3.53
Trnascriptome analysis of HeLa cells infected with rTHOV-wt, -dML, -SW mutant or mock-treated 3.48
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 3.45
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 3.45
Comprehensive comparative analysis of 5’ end RNA sequencing methods 3.39
ARID1A and ARID1B loss in HCT116 and TOV21G cells 3.37
Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells 3.34
RNA-seq of RKO cells with cTAZ KO or putback 3.33
KSDM1b Role in Ewing Sarcoma 3.33
Characterization of Type I Interferon pathway during Hepatic Differentiation of Human Pluripotent Stem Cells and hepatitis C virus infection 3.31
Analysis of chromosomal aberrations and recombination by allelic bias in RNA-Seq 3.27
Functional Haploid Human Oocytes Generated from Polar Body Genomes (RNA-Seq) 3.19
Functional Haploid Human Oocytes Generated from Polar Body Genomes 3.19
Inhibition of Enhancer of Zeste Homologue 2 attenuates TGF-β dependent hepatic stellate cell activation and liver fibrosis 3.19
Specific modulation of HIV RNA splicing and upregulation of anti-inflammatory miR-124 by the new drug candidate ABX464 3.18
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 3.16
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 3.08
Low H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 3.06
Small-molecule targeting of brachyury transcription factor addiction in chordoma 3.05
Functional and genomic characterization of a xenograft model system for the study of metastasis in triple-negative breast cancer. 3.02
Metastasis in triple-negative breast cancer 3.02
Gene expression analysis upon mtDNA depletion [RNA-seq] 3.02
Gene expression analysis upon mtDNA depletion 3.02
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 3.01
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 3.01
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis[Ribosome Profiling] 2.98
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 2.97
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 2.97
GATA3 enhances the neurogenic potential of primary human astrocytes after traumatic injury [exp2] 2.97
Effect of PRDM11 depletion in U2932 cells 2.97
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 2.95
Control of gene expression in senescence through transcriptional read-through of convergent protein-coding genes 2.95
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 2.94
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 2.91
Inhibition of the Aryl Hydrocarbon Receptor - Polyamine Biosynthesis Axis Suppresses Multiple Myeloma and prostate cancer progression 2.9
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 2.9
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 2.88
siRNA-mediated silencing of ORAI3 in MDA-MB-468 breast cancer cells exposed to hypoxia 2.85
C9/ALS Human Embryonic Stem Cells and C9/ALS Induced Pluripotent Stem Cells 2.85
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq2] 2.83
Small-molecule-based Human Genome G4 Profiling Reveals Potential Gene Regulation Activity 2.82
m6A-dependent regulation of messenger RNA stability 2.79
Gene expression profiling of KSHV-infected periodontal ligament cells 2.78
EPCR Expression Defines the Most Primitive Subset of Human HSPC and Is Required for Their In Vivo Activity 2.74
Transcriptome profiling of H1-iCas9 cells grown on laminin and on MEFs 2.73
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] 2.73
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation 2.73
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability 2.73
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) 2.73
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 2.6
RNA-seq of cultured human kidney peritubular microvascular endothelial cells following exposure to cyclosporine A 2.53
4sUDRB-seq: measuring transcription elongation and initiation genomewide 2.52
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 2.5
RNA sequencing of CACO-2 cells incubated with Bifidobacteria breve grown on human milk oligosaccharides. 2.46
SQSTM1/p62-directed metabolic reprogramming is essential for normal neurodifferentiation 2.39
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 2.32
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 2.24
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 2.24
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia 2.23
FMR1 reactivating treatments in Fragile X iPSC-derived neural progenitors in-vitro and in-vivo 2.19
Gene expression profiling associated with knockdown of RNF20 in human normal and malignant lung epithelial cell lines 2.16
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 2.13
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 2.11
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 2.1
Identification of global XBP1s target gene expression in human prostate cancer cells 2.1
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 2.09
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 2.05
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 2.04
The circadian transcriptional landscape in primary human mammary epithelial cells 2.03
Transcriptome landscape of HeLa response upon triamcinolone acetonide 2.03
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 2.01
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 2.0
HBEC-shp53-PCHD7 1.98
Gene expression profile in breast cancer cells 1.98
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 1.98
Epithelial-mesenchymal transition markers screenedina cell-based model and validated in lung adenocarcinoma 1.94
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes [RNA-seq] 1.92
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes 1.92
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses 1.91
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer 1.82
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer [RNA-Seq] 1.82
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 1.81
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 1.81
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [inhibitor MRT199665] 1.79
Multi-omic measurements of heterogeneity in HeLa cells across laboratories 1.79
CD90 Identifies Adventitial Mesenchymal Progenitor Cells in Adult Humans 1.74
The Regulation of IFN Type I Pathway Related Genes RSAD2 and ETV7 Specifically Indicate Antibody-Mediated Rejection After Kidney Transplantation 1.73
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 1.73
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 1.73
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 1.66
Effects of transcription on genome - nuclear lamina interactions: RNA-seq data 1.54
Effects of transcription on genome - nuclear lamina interactions 1.54
Transcriptomic profiling of human peripheral blood-derived mast cells 1.53
Genome-wide analyses of chromatin state in human mast cells reveal molecular drivers and mediators of allergic and inflammatory diseases 1.53
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 1.52
Defective structural RNA processing in relapsing-remitting multiple sclerosis 1.51
Effect of BCL11B knockdown on transcriptome of human T-cell precursors 1.48
Ribosome profiling of TGFb-treated cells indicates reduced leucine availability 1.45
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 1.45
Next Generation Sequencing (RNA-Sequencing) for the analysis of RUNX3 targets in H460, H460-ERT2-RUNX3 WT and H460-ERT2-RUNX3 MT(K94/171R mutation) 1.42
A stably self-renewing adult blood-derived induced neural stem cell exhibiting patternability and epigenetic rejuvenation 1.42
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 1.41
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 1.34
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 1.29
An optimization system for isolating and sequencing of single human colon cancer cells 1.24
Evolutionary origin and functional divergence of stem cell homeobox genes in eutherian mammals 1.22
Functional significance of the HIV-1 Tat signature amino acid residues 1.22
Identification of transcripts altered upon LIN-41 knockdown in human embryonic stem cells 1.19
Non-inflammatory tumor microenvironment of Diffuse Intrinsic Pontine Glioma (DIPG) 1.16
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 1.15
Sodium butyrate ameliorates aSyn-induced transcription deregulation and DNA damage 1.14
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 1.06
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 1.02
lncRNA expression analysis in patients with eosinophilic and neutrophilic asthma 0.98
Primate-specific gene TMEM14B promotes cortical expansion and folding 0.92
Long noncoding RNA signatures induced by TLR7 and type I IFN signaling in activated human plasmacytoid dendritic cells 0.89
A20 regulates canonical wnt-signaling through an interaction with RIPK4 0.89
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells 0.88
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells (RNA-seq) 0.88
Primate transcript and protein expression levels evolve under compensatory selection pressures 0.88
Effects of a nutritional supplement in older individuals subject to ten days of complete bed rest. 0.85
Gene expression profile of human placenta from T. Cruzi infected mothers 0.85
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 0.83
Transcriptomic analysis of human coronary artery endothelial cells stimulated with TNF-alpha in the presence and absence of ACSL3 siRNA 0.79
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 0.79
Differential LINE-1 retrotransposition in induced pluripotent stem cells between humans and great apes 0.77
Transcriptome profiling of 5 human adenocarcinoma cell lines 0.76
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors [RNA-seq 2] 0.76
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 0.75
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 0.74
The dynamic landscape of coding and non-coding RNAs in the innate immune response to microbial pathogens 0.73
Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML) 0.72
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 1) 0.71
RNA-seq of IL-4 stimulated human keratinocytes 0.68
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 0.67
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 0.67
UMI-count modeling and differential expression analysis for single-cell RNA sequencing 0.67
High-resolution comparative analysis of great ape genomes 0.64
Impact of Escherichia coli K12 and O18 on human platelets: effects on platelet activation, spliced platelet RNAs and proteins 0.62
Gene expression profiles of 4-1BB+PD-1-high, 4-1BB-PD-1-high, and PD-1-int tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.62
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 0.57
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 0.57
An intramolecular salt bridge linking TDP43’s RNA recognition motifs dictates RNA binding, protein stability and TDP43-dependent neurodegeneration 0.56
Transcriptional profiling identifies differential expression of long non-coding RNAs in Jo-1 associated and inclusion body myositis 0.56
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 0.56
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 0.56
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 0.53
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 [RNA-Seq] 0.53
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 0.53
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 0.53
single cell RNA-seq from GM12878 (ENCSR673UIY) 0.49
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies 0.47
ADAR1-editing of cellular and measles virus-derived duplex RNA 0.46
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 0.46
Preclinical model of obesity and ER-positive breast cancer 0.45
Transcriptome of human ILC2s; primary vs IL-1b-primed 0.44
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 0.44
A novel non-canonical signaling pathway mediates TGF-β1-induced glucocorticoid insensitivity in epithelial cells 0.39
Aging-associated patterns in the expression of human endogenous retroviruses 0.38
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 0.38
Modulation of nonsense-mediated decay by rapamycin 0.38
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis 0.35
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis [RNA-Seq_Hs] 0.35
WNT signaling memory is required for ACTIVIN to function as a morphogen 0.35
Single Cell Sequencing Reveals Gene Expression Signatures Associated with Bone Marrow Stromal Cell Subpopulations and Time in Culture [NGS_bulk cell RNA-seq] 0.34
Generating Patterned Kidney Organoids for Studying Development and Diseases [bulk RNA-Seq] 0.29
Transcriptome-wide modulation of splicing by the exon junction complex 0.26
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma 0.26
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma (RNA-Seq) 0.26
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 0.22
Expression of the mannose receptor (CD206) defines distinct populations of human colonic macrophages in health and inflammatory bowel disease 0.19
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.16
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.14
RNA-Seq of LRRK2 G2019S Parkinson’s iPSC-derived astrocytes 0.14
Discovering human diabetes-risk gene function with genetics and physiological assays 0.14
Function and hormonal regulation of GATA3 in human first trimester placentation 0.11
Transcriptomic analysis of ERR alpha orphan nuclear receptor 0.08
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  0.08
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 0.08
RNA-seq data 0.06
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 0.06
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 0.06
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress [human] 0.03
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress 0.03
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.03
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 0.02
CD133hi, Notchhi, DP (double positive) and DN (double negative) in GBML8 and GBML20, both patient-derived glioblastoma tumorsphere cultures 0.01
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.01
The NFkB subunit RELA is a master transcriptional regulator of the committed epithelial-mesenchymal transition in airway epithelial cells 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation